93 related articles for article (PubMed ID: 17620307)
1. Inactivation of p27Kip1 promotes chemical mouse liver tumorigenesis in the resistant strain C57BL/6J.
Sun D; Ren H; Oertel M; Sellers RS; Shafritz DA; Zhu L
Mol Carcinog; 2008 Jan; 47(1):47-55. PubMed ID: 17620307
[TBL] [Abstract][Full Text] [Related]
2. Loss of p27Kip1 enhances tumor progression in chronic hepatocyte injury-induced liver tumorigenesis with widely ranging effects on Cdk2 or Cdc2 activation.
Sun D; Ren H; Oertel M; Sellers RS; Zhu L
Carcinogenesis; 2007 Sep; 28(9):1859-66. PubMed ID: 17434927
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine.
Moore MR; Drinkwater NR; Miller EC; Miller JA; Pitot HC
Cancer Res; 1981 May; 41(5):1585-93. PubMed ID: 7214332
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.
Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ
Oncogene; 2004 Jan; 23(4):905-13. PubMed ID: 14647411
[TBL] [Abstract][Full Text] [Related]
5. Modulation of liver tumorigenesis in Connexin32-deficient mouse.
Luebeck EG; Buchmann A; Schneider D; Moolgavkar SH; Schwarz M
Mutat Res; 2005 Feb; 570(1):33-47. PubMed ID: 15680401
[TBL] [Abstract][Full Text] [Related]
6. Role of apoptosis for mouse liver growth regulation and tumor promotion: comparative analysis of mice with high (C3H/He) and low (C57Bl/6J) cancer susceptibility.
Bursch W; Grasl-Kraupp B; Wastl U; Hufnagl K; Chabicovsky M; Taper H; Schulte-Hermann R
Toxicol Lett; 2004 Apr; 149(1-3):25-35. PubMed ID: 15093245
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
Damo LA; Snyder PW; Franklin DS
Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
[TBL] [Abstract][Full Text] [Related]
8. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.
Denicourt C; Saenz CC; Datnow B; Cui XS; Dowdy SF
Cancer Res; 2007 Oct; 67(19):9238-43. PubMed ID: 17909030
[TBL] [Abstract][Full Text] [Related]
9. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
Rignall B; Braeuning A; Buchmann A; Schwarz M
Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
[TBL] [Abstract][Full Text] [Related]
10. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F
Gastroenterology; 2008 Mar; 134(3):781-92. PubMed ID: 18325391
[TBL] [Abstract][Full Text] [Related]
11. Abnormal development of mouse embryoid bodies lacking p27Kip1 cell cycle regulator.
Bryja V; Cajánek L; Pacherník J; Hall AC; Horváth V; Dvorák P; Hampl A
Stem Cells; 2005 Aug; 23(7):965-74. PubMed ID: 15941856
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis.
Leung N; Turbide C; Olson M; Marcus V; Jothy S; Beauchemin N
Oncogene; 2006 Sep; 25(40):5527-36. PubMed ID: 16619040
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of p27kip1 promotes chemical hepatocarcinogenesis through enhancing inflammatory cytokine secretion and STAT3 signaling activation.
Guo J; Ma Q; Zhou X; Fan P; Shan T; Miao D
J Cell Physiol; 2013 Oct; 228(10):1967-76. PubMed ID: 23460367
[TBL] [Abstract][Full Text] [Related]
14. Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kip1-deficient mice.
King TJ; Lampe PD
Cell Commun Adhes; 2005; 12(5-6):293-305. PubMed ID: 16531324
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27 kip1 gene using lyophilized lipid-polycation-DNA complexes.
Sun X; Zhang HW; Zhang ZR
J Gene Med; 2009 Jun; 11(6):535-44. PubMed ID: 19326369
[TBL] [Abstract][Full Text] [Related]
16. The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Polyak K
Cancer Cell; 2006 Nov; 10(5):352-4. PubMed ID: 17097557
[TBL] [Abstract][Full Text] [Related]
17. In vivo significance of the G2 restriction point.
Foijer F; Delzenne-Goette E; Dekker M; Te Riele H
Cancer Res; 2007 Oct; 67(19):9244-7. PubMed ID: 17909031
[TBL] [Abstract][Full Text] [Related]
18. Ablation of p27 enhance kainate-induced seizure and hippocampal degeneration.
Ueyama C; Akashiba H; Nakayama K; Nakayama KI; Nishiyama N; Matsuki N
Neuroreport; 2007 Nov; 18(17):1781-5. PubMed ID: 18090311
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions.
Kakehashi A; Kato A; Inoue M; Ishii N; Okazaki E; Wei M; Tachibana T; Wanibuchi H
Toxicol Appl Pharmacol; 2010 Jan; 242(1):47-55. PubMed ID: 19796649
[TBL] [Abstract][Full Text] [Related]
20. Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice.
Fedele M; Palmieri D; Chiappetta G; Pasquinelli R; De Martino I; Arra C; Palma G; Valentino T; Pierantoni GM; Viglietto G; Rothstein JL; Santoro M; Fusco A
Endocr Relat Cancer; 2009 Jun; 16(2):483-90. PubMed ID: 19261681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
